KYMR

Kymera Therapeutics (KYMR)

About Kymera Therapeutics (KYMR)

Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi in September 2015 and is headquartered in Watertown, MA.

Details

Daily high

$40.78

Daily low

$38.24

Price at open

$38.66

52 Week High

$53.27

52 Week Low

$22.35

Market cap

2.6B

Dividend yield

0.00%

Volume

1.1M

Avg. volume

531,135

P/E ratio

-17.46

Kymera Therapeutics News